KZIA · Insider Trading
Kazia Therapeutics Limited American Depositary Shares
Every open-market purchase and sale reported by KZIA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Steven R. S. Coffey | Director | A | +100,000 deriv. | — |
| 2026-07-08 | Robert F Apple | Director | A | +75,000 deriv. | — |
| 2026-07-08 | David Cain | Director, CMC | A | +100,000 deriv. | — |
| 2026-07-08 | John E. Friend II | Chief Executive Officer | A | +350,000 deriv. | — |
| 2026-07-08 | Jeffrey Bonacorda | VP, Finance and Controller | A | +150,000 deriv. | — |
| 2026-07-08 | Ebru Davidson | Director | A | +100,000 deriv. | — |
| 2026-06-23 | James E. Levine | Chief Financial Officer | A | +200,000 deriv. | — |
| 2026-06-23 | Sudha Rao | Chief Scientific Officer | A | +250,000 deriv. | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KZIA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.